These results revealed that decreased salivary lactoferrin levels are AD-specific biomarkers and are helpful in differentiating and diagnosing the early clinical stages of AD, as well as in predicting the development and progression of cognitive disorders in AD [51]. This evidence concerns the gene LTF and Cognitive impairment.